Clinical Trials
3 trialsNCT03906331 2025-01-17
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Eli Lilly and Company
Approved for marketing
NCT01480128 2020-06-19
SIMPLE
The Catholic University of Korea
Approved for marketing
NCT01267461 2012-08-10
Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
Meir Medical Center
Available